Smart biomaterials for tissue engineering of cartilage

Injury

Volumn 39, Issue 1 SUPPL., 2008, Pages 77-87

  Stoop, Reinout ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Biomaterials; Chondrocytes; Drug delivery; Tissue engineering

Indexed keywords

BIOMATERIAL; BONE MORPHOGENETIC PROTEIN 2; COLLAGEN; COLLAGENASE 3; DACRON; FIBRIN; FIBROBLAST GROWTH FACTOR 2; GELATIN; GROWTH FACTOR; HYALURONIC ACID; HYALURONIC ACID DERIVATIVE; INSULIN; LIPOSOME; MICROSPHERE; OSTEOGENIC PROTEIN 1; PLATELET DERIVED GROWTH FACTOR BB; POLITEF; POLYMER; POLYURETHAN; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA3;

ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CARTILAGE INJURY; CELL DIFFERENTIATION; CELL METABOLISM; CULTURE MEDIUM; DRUG DELIVERY SYSTEM; ENVIRONMENTAL FACTOR; EXTRACELLULAR MATRIX; GROWTH STIMULATION; HUMAN; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; TISSUE ENGINEERING; TISSUE REGENERATION;

EID: 39749096814     PISSN: 00201383     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.injury.2008.01.036     Document Type: Article

References (119)

1. Alsberg E., Anderson K.W., Albeiruti A., et al. Engineering growing tissues. Proc Natl Acad Sci USA 99 19 (2002) 12025-12030
2. Altman R.D., Kates J., Chun L.E., et al. Preliminary observations of chondral abrasion in a canine model. Ann Rheum Dis 51 9 (1992) 1056-1062
3. Andereya S., Maus U., Gavenis K., et al. [First clinical experiences with a novel 3D-collagen gel (CaReS) for the treatment of focal cartilage defects in the knee]. Z Orthop Ihre Grenzgeb 144 3 (2006) 272-280
4. Appel B., Maschke A., Weiser B., et al. Lipidic implants for controlled release of bioactive insulin: effects on cartilage engineered in vitro. Int J Pharm 314 2 (2006) 170-178
5. Barbucci R., Torricelli P., Fini M., et al. Proliferative and re-defferentiative effects of photo-immobilized micro-patterned hyaluronan surfaces on chondrocyte cells. Biomaterials 26 36 (2005) 7596-7605
6. Bentley G., Biant L.C., Carrington R.W., et al. A prospective, randomized comparison of autologous chondrocyte implantation versus mosaicplasty for osteochondral defects in the knee. J Bone Joint Surg Br 85 2 (2003) 223-230
7. Brandstedt S., Rank F., and Olson P.S. Wound healing and formation of granulation tissue in normal and defibrinogenated rabbits. An experimental model and histological study. Eur Surg Res 12 1 (1980) 12-21
8. Brittberg M., Sjogren-Jansson E., Lindahl A., et al. Influence of fibrin sealant (Tisseel) on osteochondral defect repair in the rabbit knee. Biomaterials 18 3 (1997) 235-242
9. Bryant S.J., and Anseth K.S. Hydrogel properties influence ECM production by chondrocytes photoencapsulated in poly(ethylene glycol) hydrogels. J Biomed Mater Res 59 1 (2002) 63-72
10. Bryant S.J., Chowdhury T.T., Lee D.A., et al. Crosslinking density influences chondrocyte metabolism in dynamically loaded photocrosslinked poly(ethylene glycol) hydrogels. Ann Biomed Eng 32 3 (2004) 407-417
11. Burrage P.S., and Brinckerhoff C.E. Molecular targets in osteoarthritis: metalloproteinases and their inhibitors. Curr Drug Targets 8 2 (2007) 293-303
12. Chen J.P., and Cheng T.H. Thermo-responsive chitosan-graft-poly(Nisopropylacrylamide) injectable hydrogel for cultivation of chondrocytes and meniscus cells. Macromol Biosci 6 12 (2006) 1026-1039
13. Cherubino P., Grassi F.A., Bulgheroni P., et al. Autologous chondrocyte implantation using a bilayer collagen membrane: a preliminary report. J Orthop Surg (Hong Kong) 11 1 (2003) 10-15
14. Chou C.H., Cheng W.T., Kuo T.F., et al. Fibrin glue mixed with gelatin/hyaluronic acid/chondroitin-6-sulfate tri-copolymer for articular cartilage tissue engineering: The results of real-time polymerase chain reaction. J Biomed Mater Res A (2007) [Epub ahead of print]
15. Cima L.G., Vacanti J.P., Vacanti C., et al. Tissue engineering by cell transplantation using degradable polymer substrates. J Biomech Eng 113 2 (1991) 143-151
16. Connelly J.T., Garcia A.J., and Levenston M.E. Inhibition of in vitro chondrogenesis in RGD-modified three-dimensional alginate gels. Biomaterials 28 6 (2007) 1071-1083
17. Cook S.D., Patron L.P., Salkeld S.L., et al. Repair of articular cartilage defects with osteogenic protein-1 (BMP-7) in dogs. J Bone Joint Surg Am 85-A Suppl 3 (2003) 116-123
18. Curtis A.S., and Wilkinson C.D. Reactions of cells to topography. J Biomater Sci Polym Ed 9 12 (1998) 1313-1329
19. DeFail A.J., Chu C.R., Izzo N., et al. Controlled release of bioactive TGF-beta 1 from microspheres embedded within biodegradable hydrogels. Biomaterials 27 8 (2006) 1579-1585
20. Dedhar S. Cell-substrate interactions and signaling through ILK. Curr Opin Cell Biol 12 2 (2000) 250-256
21. Defrere J., and Franckart A. Teflon/polyurethane arthroplasty of the knee: the first 2 years preliminary clinical experience in a newconcept of artificial resurfacing of full thickness cartilage lesions of the knee. Acta Chir Belg 92 5 (1992) 217-227
22. Di Martino A., Sittinger M., and Risbud M.V. Chitosan: a versatile biopolymer for orthopaedic tissue-engineering. Biomaterials 26 30 (2005) 5983-5990
23. Durr J., Goodman S., Potocnik A., et al. Localization of beta 1-integrins in human cartilage and their role in chondrocyte adhesion to collagen and fibronectin. Exp Cell Res 207 2 (1993) 235-244
24. Elisseeff J., McIntoshW, Fu K., et al. Controlled-release of IGF-I and TGF-beta1 in a photopolymerizing hydrogel for cartilage tissue engineering. J Orthop Res 19 6 (2001) 1098-1104
25. Enomoto M., Leboy P.S., Menko A.S., et al. Beta 1 integrins mediate chondrocyte interaction with type I collagen, type II collagen, and fibronectin. Exp Cell Res 205 2 (1993) 276-285
26. Facchini A., Lisignoli G., Cristino S., et al. Human chondrocytes and mesenchymal stem cells grown onto engineered scaffold. Biorheology 43 3-4 (2006) 471-480
27. Fan H., Hu Y., Li X., et al. Ectopic cartilage formation induced by mesenchymal stem cells on porous gelatin-chondroitinhyaluronate scaffold containing microspheres loaded with TGF-beta1. Int J Artif Organs 29 6 (2006) 602-611
28. Fan H., Hu Y., Qin L., et al. Porous gelatin-chondroitin-hyaluronate tri-copolymer scaffold containing microspheres loaded with TGF-beta1 induces differentiation ofmesenchymal stem cells in vivo for enhancing cartilage repair. J Biomed Mater Res A 77 4 (2006) 785-794
29. Fan H., Hu Y., Zhang C., et al. Cartilage regeneration using mesenchymal stem cells and a PLGA-gelatin/chondroitin/hyaluronate hybrid scaffold. Biomaterials 27 26 (2006) 4573-4580
30. Farrell E., O'Brien F.J., Doyle P., et al. A collagen-glycosaminoglycan scaffold supports adult rat mesenchymal stem cell differentiation along osteogenic and chondrogenic routes. Tissue Eng 12 3 (2006) 459-468
31. Fisher J.P., Jo S., Mikos A.G., et al. Thermoreversible hydrogel scaffolds for articular cartilage engineering. J Biomed Mater Res A 71 2 (2004) 268-274
32. Frenkel S.R., Toolan B., Menche D., et al. Chondrocyte transplantation using a collagen bilayermatrix for cartilage repair. J Bone Joint Surg Br 79 5 (1997) 831-836
33. Fujisato T., Sajiki T., LiuQ, et al. Effect of basic fibroblast growth factor on cartilage regeneration in chondrocyte-seeded collagen sponge scaffold. Biomaterials 17 2 (1996) 155-162
34. Gao J., Dennis J.E., Solchaga L.A., et al. Tissue-engineered fabrication of an osteochondral composite graft using rat bone marrow-derived mesenchymal stem cells. Tissue Eng 7 4 (2001) 363-371
35. Garcia A., Collard D., Keselowsky B., et al. Engineering of integrin-specific biomimetic surfaces to control cell adhesion and function. AK. D,AM. L. Biomimetic materials and designs (2002), Marcel Dekker, Inc, New York pp. 29-53
36. Giancotti F.G. Complexity and specificity of integrin signalling. Nat Cell Biol 2 1 (2000) E13-E14
37. Gille J., MeisnerU, Ehlers E.M., et al. Migration pattern,morphology and viability of cells suspended in or sealedwith fibrin glue: a histomorphologic study. Tissue Cell 37 5 (2005) 339-348
38. Goa K.L., and Benfield P. Hyaluronic acid. A review of its pharmacology and use as a surgical aid in ophthalmology, and its therapeutic potential in joint disease and wound healing. Drugs 47 3 (1994) 536-566
39. GobbiA, Kon E., Berruto M., et al. Patellofemoral full-thickness chondral defects treatedwithHyalograft-C: a clinical, arthroscopic, and histologic review. Am J Sports Med 34 11 (2006) 1763-1773
40. Gordon T.D., Schloesser L., Humphries D.E., et al. Effects of the degradation rate of collagen matrices on articular chondrocyte proliferation and biosynthesis in vitro. Tissue Eng 10 7-8 (2004) 1287-1295
41. Hanff G., Sollerman C., Abrahamsson S.O., et al. Repair of osteochondral defects in the rabbit knee with Gore-Tex (expanded polytetrafluoroethylene). An experimental study. Scand J Plast Reconstr Surg Hand Surg 24 3 (1990) 217-223
42. Harbers G., Barber T., Stile R., et al. Mimetic peptide-modified materials for control of cell differentiation. DillowA, Lowman A, Biomimeticmaterials and design (2002), Marcel Dekker, Inc, NewYork pp. 55-90
43. Hoemann C.D., Sun J., Legare A., et al. Tissue engineering of cartilage using an injectable and adhesive chitosan-based cell-delivery vehicle. Osteoarthritis Cartilage 13 4 (2005) 318-329
44. Hofmann S., Knecht S., Langer R., et al. Cartilage-like Tissue Engineering Using Silk Scaffolds andMesenchymal Stem Cells. Tissue Eng (2006) [Epub ahead of print]
45. Holland T.A., Bodde E.W., Cuijpers V.M., et al. Degradable hydrogel scaffolds for in vivo delivery of single and dual growth factors in cartilage repair. Osteoarthritis Cartilage 15 2 (2007) 187-197
46. Holland T.A., Tabata Y., and Mikos A.G. Dual growth factor delivery from degradable oligo(poly(ethylene glycol) fumarate) hydrogel scaffolds for cartilage tissue engineering. J Control Release 101 1-3 (2005) 111-125
47. Holland T.A., Tessmar J.K., Tabata Y., et al. Transforming growth factor-beta 1 release from oligo(poly(ethylene glycol) fumarate) hydrogels in conditions that model the cartilage wound healing environment. J Control Release 94 1 (2004) 101-114
48. HollanderAP, Dickinson S.C., Sims T.J., et al. Maturation of tissue engineered cartilage implanted in injured and osteoarthritic human knees. Tissue Eng 12 7 (2006) 1787-1798
49. Homminga G.N., Buma P., Koot H.W., et al. Chondrocyte behavior in fibrin glue in vitro. Acta Orthop Scand 64 4 (1993) 441-445
50. Hsu S.H., Chang S.H., Yen H.J., et al. Evaluation of biodegradable polyesters modified by type II collagen and Arg-Gly-Asp as tissue engineering scaffolding materials for cartilage regeneration. Artif Organs 30 1 (2006) 42-55
51. Hubbell J.A. Materials as morphogenetic guides in tissue engineering. Curr Opin Biotechnol 14 5 (2003) 551-558
52. Hunziker E.B. Articular cartilage repair: basic science and clinical progress. Areviewof the current status and prospects. Osteoarthritis Cartilage 10 6 (2002) 432-463
53. Hunziker E.B., Driesang I.M., and Saager C. Structural barrier principle for growth factor-based articular cartilage repair. Clin Orthop Relat Res 391 Suppl (2001) S182-S189
54. Hunziker E.B., Driesang I.M., and Morris E.A. Chondrogenesis in cartilage repair is induced by members of the transforming growth factor-beta superfamily. Clin Orthop Relat Res 391 Suppl (2001) S171-S181
55. Hwang N.S., Varghese S., Zhang Z., et al. Chondrogenic differentiation of human embryonic stem cell-derived cells in arginine-glycine-aspartate-modified hydrogels. Tissue Eng 12 9 (2006) 2695-2706
56. Hynes R.O. Integrins: bidirectional, allosteric signaling machines. Cell 110 6 (2002) 673-687
57. Im G.I., Kim D.Y., Shin J.H., et al. Repair of cartilage defect in the rabbit with cultured mesenchymal stem cells from bone marrow. J Bone Joint Surg Br 83 2 (2001) 289-294
58. Kang S.W., Yoon J.R., Lee J.S., et al. The use of poly(lactic-coglycolic acid) microspheres as injectable cell carriers for cartilage regeneration in rabbit knees. J Biomater Sci Polym Ed 17 8 (2006) 925-939
59. Kang Y., Yang J., Khan S., et al. A new biodegradable polyester elastomer for cartilage tissue engineering. J Biomed Mater Res A 77 2 (2006) 331-339
60. Kaplonyi G., Zimmerman I., Frenyo A.D., et al. The use of fibrin adhesive in the repair of chondral and osteochondral injuries. Injury 19 4 (1988) 267-272
61. Kawamura S., Wakitani S., Kimura T., et al. Articular cartilage repair. Rabbit experiments with a collagen gel-biomatrix and chondrocytes cultured in it. Acta Orthop Scand 69 1 (1998) 56-62
62. Kim M.R., and Park T.G. Temperature-responsive and degradable hyaluronic acid/Pluronic composite hydrogels for controlled release of human growth hormone. J Control Release 80 1-3 (2002) 69-77
63. Kim H.D., and Valentini R.F. Retention and activity of BMP-2 in hyaluronic acid-based scaffolds in vitro. J Biomed Mater Res 59 3 (2002) 573-584
64. Kuo A.C., Rodrigo J.J., Reddi A.H., et al. Microfracture and bone morphogenetic protein 7 (BMP-7) synergistically stimulate articular cartilage repair. Osteoarthritis Cartilage 14 11 (2006) 1126-1135
65. Langer R., and Peppas N. Advances in biomaterials, drug delivery, and bionanotechnology. AIChE Journal 49 12 (2003) 2990-3006
66. Larno S., Calvet M.C., Calvet J., et al. Sodium butyrate-induced changes in cultured rabbit articular chondrocyte transmembrane electrical potentials. Relationship between these changes and the proliferative response. Life Sci 36 21 (1985) 2069-2073
67. Lee C.R., Grad S., Gorna K., et al. Fibrin-polyurethane composites for articular cartilage tissue engineering: a preliminary analysis. Tissue Eng 11 9-10 (2005) 1562-1573
68. Lee J.E., Kim K.E., Kwon I.C., et al. Effects of the controlledreleased TGF-beta 1 from chitosan microspheres on chondrocytes cultured in a collagen/chitosan/glycosaminoglycan scaffold. Biomaterials 25 18 (2004) 4163-4173
69. Lee K.Y., Peters M.C., Anderson K.W., et al. Controlled growth factor release from synthetic extracellular matrices. Nature 408 6815 (2000) 998-1000
70. Li W.J., Jiang Y.J., and Tuan R.S. Chondrocyte phenotype in engineered fibrous matrix is regulated by fiber size. Tissue Eng 12 7 (2006) 1775-1785
71. Lisignoli G., Cristino S., Piacentini A., et al. Cellular and molecular events during chondrogenesis of human mesenchymal stromal cells grown in a three-dimensional hyaluronan based scaffold. Biomaterials 26 28 (2005) 5677-5686
72. Loeser R.F. Integrin-mediated attachment of articular chondrocytes to extracellular matrix proteins. Arthritis Rheum 36 8 (1993) 1103-1110
73. Lohmann C.H., Schwartz Z., Niederauer G.G., et al. Pretreatment with platelet derived growth factor-BB modulates the ability of costochondral resting zone chondrocytes incorporated into PLA/PGAscaffolds to formnewcartilage in vivo. Biomaterials 21 1 (2000) 49-61
74. Lu L., Stamatas G.N., and Mikos A.G. Controlled release of transforming growth factor beta1 from biodegradable polymer microparticles. J Biomed Mater Res 50 3 (2000) 440-451
75. Lukashev M.E., and Werb Z. ECM signalling: orchestrating cell behaviour and misbehaviour. Trends Cell Biol 8 11 (1998) 437-441
76. Lutolf M.P., and Hubbell J.A. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat Biotechnol 23 1 (2005) 47-55
77. Ma P.X., and Langer R. Morphology and mechanical function of long-term in vitro engineered cartilage. J Biomed Mater Res 44 2 (1999) 217-221
78. MahmoodTA, Shastri V.P., van Blitterswijk C.A., et al. Tissue engineering of bovine articular cartilage within porous poly(ether ester) copolymer scaffolds with different structures. Tissue Eng 11 7-8 (2005) 1244-1253
79. MarcacciM, BerrutoM, Brocchetta D., et al. Articular cartilage engineering with Hyalograft C: 3-year clinical results. Clin Orthop Relat Res 435 (2005) 96-105
80. Marlovits S., Striessnig G., Kutscha-Lissberg F., et al. Early postoperative adherence of matrix-induced autologous chondrocyte implantation for the treatment of full-thickness cartilage defects of the femoral condyle. Knee Surg Sports Traumatol Arthrosc 13 6 (2005) 451-457
81. Martin I., Suetterlin R., Baschong W., et al. Enhanced cartilage tissue engineering by sequential exposure of chondrocytes to FGF-2 during 2D expansion and BMP-2 during 3D cultivation. J Cell Biochem 83 1 (2001) 121-128
82. McBeath R., Pirone D.M., Nelson C.M., et al. Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment. Dev Cell 6 4 (2004) 483-495
83. Messner K., and Gillquist J. Synthetic implants for the repair of osteochondral defects of the medial femoral condyle: a biomechanical and histological evaluation in the rabbit knee. Biomaterials 14 7 (1993) 513-521
84. Miot S., Scandiucci de Freitas P., Wirz D., et al. Cartilage tissue engineering by expanded goat articular chondrocytes. J Orthop Res 24 5 (2006) 1078-1085
85. Na K., KimS, Woo D.G., et al. Synergistic effect of TGFbeta-3 on chondrogenic differentiation of rabbit chondrocytes in thermo- reversible hydrogel constructs blended with hyaluronic acid by in vivo test. J Biotechnol 128 2 (2007) 412-422
86. Na K., Park J.H., Kim S.W., et al. Delivery of dexamethasone, ascorbate, and growth factor (TGF beta-3) in thermo-reversible hydrogel constructs embedded with rabbit chondrocytes. Biomaterials 27 35 (2006) 5951-5957
87. Nehrer S., Domayer S., Dorotka R., et al. Three-year clinical outcome after chondrocyte transplantation using a hyaluronan matrix for cartilage repair. Eur J Radiol 57 1 (2006) 3-8
88. Nuttelman C.R., Tripodi M.C., and Anseth K.S. Synthetic hydrogel niches that promote hMSC viability. Matrix Biol 24 3 (2005) 208-218
89. Oliveira J.M., Rodrigues M.T., Silva S.S., et al. Novel hydroxyapatite/chitosan bilayered scaffold for osteochondral tissueengineering applications: Scaffold design and its performance when seededwith goat bonemarrowstromal cells. Biomaterials 27 36 (2006) 6123-6137
90. Poole C.A., Honda T., Skinner S.J., et al. Chondrons from articular cartilage (II): Analysis of the glycosaminoglycans in the cellular microenvironment of isolated canine chondrons. Connect Tissue Res 24 3-4 (1990) 319-330
91. Pulkkinen H., Tiitu V., Lammentausta E., et al. Cellulose sponge as a scaffold for cartilage tissue engineering. Biomed Mater Eng 16 4 Suppl (2006) S29-S35
92. Ruoslahti E. RGD and other recognition sequences for integrins. Annu Rev Cell Dev Biol 12 (1996) 697-715
93. Santiago L.Y., Nowak R.W., Peter Rubin J., et al. Peptide-surface modification of poly(caprolactone) with laminin-derived sequences for adipose-derived stem cell applications. Biomaterials 27 15 (2006) 2962-2969
94. Schmidt A., Ladage D., Schinkothe T., et al. Basic fibroblast growth factor controlsmigration in humanmesenchymal stem cells. Stem Cells 24 7 (2006) 1750-1758
95. Seeherman H., and Wozney J.M. Delivery of bone morphogenetic proteins for orthopedic tissue regeneration. Cytokine Growth Factor Rev 16 3 (2005) 329-345
96. Segat D., Comai R., Di Marco E., et al. Integrins alpha(6A)beta 1 and alpha(6B)beta 1 promote different stages of chondrogenic cell differentiation. J Biol Chem 277 35 (2002) 31612-31622
97. Seliktar D., Zisch A.H., Lutolf M.P., et al. MMP-2 sensitive, VEGFbearing bioactive hydrogels for promotion of vascular healing. J Biomed Mater Res A 68 4 (2004) 704-716
98. Sellers R.S., Peluso D., and Morris E.A. The effect of recombinant human bone morphogenetic protein-2 (rhBMP-2) on the healing of full-thickness defects of articular cartilage. J Bone Joint Surg Am 79 10 (1997) 1452-1463
99. Sellers R.S., Zhang R., Glasson S.S., et al. Repair of articular cartilage defects one year after treatment with recombinant human bone morphogenetic protein-2 (rhBMP-2). J Bone Joint Surg Am 82 2 (2000) 151-160
100. Shao X., Goh J.C., Hutmacher D.W., et al. Repair of large articular osteochondral defects using hybrid scaffolds and bone marrow-derived mesenchymal stem cells in a rabbit model. Tissue Eng 12 6 (2006) 1539-1551
101. Shapiro F., Koide S., and Glimcher M.J. Cell origin and differentiation in the repair of full-thickness defects of articular cartilage. J Bone Joint Surg Am 75 4 (1993) 532-553
102. Sinha R.K., Morris F., Shah S.A., et al. Surface composition of orthopaedic implant metals regulates cell attachment, spreading, and cytoskeletal organization of primary human osteoblasts in vitro. Clin Orthop Relat Res 305 (1994) 258-272
103. Solchaga L.A., Gao J., Dennis J.E., et al. Treatment of osteochondral defects with autologous bone marrow in a hyaluronan-based delivery vehicle. Tissue Eng 8 2 (2002) 333-347
104. Steadman J.R., Rodkey W.G., and Rodrigo J.J. Microfracture: surgical technique and rehabilitation to treat chondral defects. Clin Orthop Relat Res 391 Suppl (2001) S362-S369
105. Stoop R, Sapei L, Gaissmaier C, Scharstuhl A, Kellomäki M, Ellä V, et al. Woven P(L/D)LA scaffolds for cartilage tissue engineering. In: ECM V-The Cell Biomaterial Reaction; 2004; Davos: European Cells and Materials; 2004.
106. Tamai N., Myoui A., Hirao M., et al. A new biotechnology for articular cartilage repair: subchondral implantation of a composite of interconnected porous hydroxyapatite, synthetic polymer (PLA-PEG), and bone morphogenetic protein-2 (rhBMP-2). Osteoarthritis Cartilage 13 5 (2005) 405-417
107. Terrell T.G., Working P.K., Chow C.P., et al. Pathology of recombinant human transforming growth factor-beta 1 in rats and rabbits. Int Rev Exp Pathol 34 Pt B (1993) 43-67
108. Vacanti C.A., Langer R., Schloo B., et al. Synthetic polymers seeded with chondrocytes provide a template for new cartilage formation. Plast Reconstr Surg 88 5 (1991) 753-759
109. van Beuningen H.M., van der Kraan P.M., Arntz O.J., et al. Transforming growth factor-beta 1 stimulates articular chondrocyte proteoglycan synthesis and induces osteophyte formation in the murine knee joint. Lab Invest 71 2 (1994) 279-290
110. van Hinsbergh V.W., Collen A., and Koolwijk P. Role of fibrin matrix in angiogenesis. Ann NY Acad Sci 936 (2001) 426-437
111. van Susante J.L., Buma P., Homminga G.N., et al. Chondrocyteseeded hydroxyapatite for repair of large articular cartilage defects. Apilot study in the goat. Biomaterials 19 24 (1998) 2367-2374
112. van Susante J.L., Buma P., Schuman L., et al. Resurfacing potential of heterologous chondrocytes suspended in fibrin glue in large full-thickness defects of femoral articular cartilage: an experimental study in the goat. Biomaterials 20 13 (1999) 1167-1175
113. van Susante J.L.C., Pieper J., Buma P., et al. Linkage of chondroitin- sulfate to type I collagen scaffolds stimulates the bioactivity of seeded chondrocytes in vitro. Biomaterials 22 17 (2001) 2359-2369
114. Veilleux N., and Spector M. Effects of FGF-2 and IGF-1 on adult canine articular chondrocytes in type II collagen-glycosaminoglycan scaffolds in vitro. Osteoarthritis Cartilage 13 4 (2005) 278-286
115. Wakitani S., Goto T., Young R.G., et al. Repair of large fullthickness articular cartilage defects with allograft articular chondrocytes embedded in a collagen gel. Tissue Eng 4 4 (1998) 429-444
116. Wang Y., Kim H.J., Vunjak-Novakovic G., et al. Stem cell-based tissue engineeringwith silk biomaterials. Biomaterials 27 36 (2006) 6064-6082
117. Wang T.W., Sun J.S., Wu H.C., et al. Evaluation and biological characterization of bilayer gelatin/chondroitin- 6-sulphate/hyaluronic acid membrane. J Biomed Mater Res B Appl Biomater (2007) [Epub ahead of print]
118. Woodfield T.B., Van Blitterswijk C.A., De Wijn J., et al. Polymer scaffolds fabricated with pore-size gradients as a model for studying the zonal organization within tissue-engineered cartilage constructs. Tissue Eng 11 9-10 (2005) 1297-1311
119. Yamada K.M. Adhesive recognition sequences. J Biol Chem 266 20 (1991) 12809-12812